{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:29:15Z","timestamp":1788323355187,"version":"build-2803163510"},"reference-count":103,"publisher":"Informa UK Limited","issue":"1-2","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Pharmacology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1080\/17512433.2024.2436433","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T13:17:46Z","timestamp":1734095866000},"page":"17-27","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":12,"title":["Targeting HIF-2\u03b1: the role of belzutifan in clear cell renal carcinoma management"],"prefix":"10.1080","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-1129-7510","authenticated-orcid":false,"given":"Alejandro","family":"Vald\u00e9s","sequence":"first","affiliation":[{"name":"Bradford Hill Clinical Research Center","place":["Santiago, Chile"]},{"name":"Instituto Nacional del C\u00e1ncer","place":["Santiago, Chile"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7712-8053","authenticated-orcid":false,"given":"Gonzalo","family":"Pizarro","sequence":"additional","affiliation":[{"name":"Bradford Hill Clinical Research Center","place":["Santiago, Chile"]},{"name":"Hospital S\u00f3tero del R\u00edo","place":["Santiago, Chile"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0324-2948","authenticated-orcid":false,"given":"Jaime","family":"Gonz\u00e1lez-Montero","sequence":"additional","affiliation":[{"name":"Bradford Hill Clinical Research Center","place":["Santiago, Chile"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Rojas","sequence":"additional","affiliation":[{"name":"Bradford Hill Clinical Research Center","place":["Santiago, Chile"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7150-4033","authenticated-orcid":false,"given":"Mauricio","family":"Burotto","sequence":"additional","affiliation":[{"name":"Bradford Hill Clinical Research Center","place":["Santiago, Chile"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,12,13]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834"},{"key":"e_1_3_5_4_1","volume-title":"Urinary and male genital tumors","author":"WHO Classification of Tumors Editorial Board, International Agency for Research on Cancer","year":"2022","unstructured":"WHO Classification of Tumors Editorial Board, International Agency for Research on Cancer. Urinary and male genital tumors. Lyon, France: International Agency for Research on Cancer; 2022."},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.79.2549"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-019-0211-5"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.1986"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)00917-6"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyab056"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3844"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1093-z"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2023.102645"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnac025"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15041316"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b00719"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2012.06.004"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2018.05.004"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trecan.2021.10.004"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc3183"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1535-6108(02)00044-2"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-11-0098"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1535-6108(02)00043-0"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0808092106"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm301847z"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-0473"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.74.2627"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-1054"},{"key":"e_1_3_5_28_1","unstructured":"National Library of Medicine (U.S.). ClinicalTrials.Gov[Internet]. [cited 2024 Aug 26]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04924075"},{"key":"e_1_3_5_29_1","unstructured":"National Library of Medicine (U.S.).ClinicalTrials.Gov [Internet]. [cited 2024 Aug 26]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT02861573"},{"key":"e_1_3_5_30_1","unstructured":"National Library of Medicine (U.S.).ClinicalTrials.Gov [Internet]. [cited 2024 Aug 26]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06428396"},{"key":"e_1_3_5_31_1","unstructured":"National Library of Medicine (U.S.).ClinicalTrials.Gov [Internet]. [cited 2024 Aug 26]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04976634"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01324-7"},{"key":"e_1_3_5_33_1","unstructured":"U.S. Food and Drug Administration. Belzutifan. Available from 2021. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/215383s000lbl.pdf"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-021-01606-x"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.13028"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2023.113434"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.09.1111"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_suppl.4534"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.10.089"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00097-9"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1510016"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30107-3"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-018-0061-6"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2020.05.009"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1177\/03008916221138881"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-48087-4"},{"key":"e_1_3_5_47_1","unstructured":"National Library of Medicine (U.S.). ClinicalTrials.Gov [Internet]. [cited 2024 Aug 23]. Available from: http:\/\/clinicaltrials.gov\/study\/NCT05030506"},{"key":"e_1_3_5_48_1","unstructured":"National Library of Medicine (U.S.).ClinicalTrials.Gov [Internet]. [cited 2024 Aug 23]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT02293980"},{"key":"e_1_3_5_49_1","unstructured":"National Library of Medicine (U.S.).ClinicalTrials.Gov [Internet]. [cited 2024 Aug 23]. Available from: http:\/\/clinicaltrials.gov\/study\/NCT04626479"},{"key":"e_1_3_5_50_1","unstructured":"National Library of Medicine (U.S.).ClinicalTrials.Gov [Internet]. [cited 2024 Aug 23]. Available from: http:\/\/clinicaltrials.gov\/study\/NCT04626518"},{"key":"e_1_3_5_51_1","unstructured":"National Library of Medicine (U.S.).ClinicalTrials.Gov [Internet]. [cited 2024 Aug 23]. Available from: http:\/\/clinicaltrials.gov\/study\/NCT05239728"},{"key":"e_1_3_5_52_1","unstructured":"National Library of Medicine (U.S.).ClinicalTrials.Gov [Internet]. [cited 2024 Aug 23]. Available from: http:\/\/clinicaltrials.gov\/study\/NCT04736706"},{"key":"e_1_3_5_53_1","unstructured":"National Library of Medicine (U.S.). ClinicalTrials.Gov [Internet]. [cited 2024 Aug 23]. Available from: http:\/\/clinicaltrials.gov\/study\/NCT05899049"},{"key":"e_1_3_5_54_1","unstructured":"National Library of Medicine (U.S.).ClinicalTrials.Gov [Internet]. [cited 2024 Aug 23]. Available from: http:\/\/clinicaltrials.gov\/study\/NCT04586231"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2313906"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2103425"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2024.05.024"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-23-2592"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2024-CT221"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.08.074"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2022.40.16_suppl.4546"},{"key":"e_1_3_5_62_1","unstructured":"National Library of Medicine (U.S.). ClinicalTrials.Gov [Internet]. [cited 2024 Aug 18]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04846920"},{"key":"e_1_3_5_63_1","unstructured":"National Library of Medicine (U.S.). ClinicalTrials.Gov [Internet]. [cited 2024 Aug 18]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06234605"},{"key":"e_1_3_5_64_1","unstructured":"National Library of Medicine (U.S.). ClinicalTrials.Gov [Internet]. [cited 2024 Aug 18]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05030506"},{"key":"e_1_3_5_65_1","unstructured":"National Library of Medicine (U.S.). ClinicalTrials.Gov [Internet]. [cited 2024 Aug 18]. Available from: http:\/\/clinicaltrials.gov\/study\/NCT02293980"},{"key":"e_1_3_5_66_1","unstructured":"National Library of Medicine (U.S.). ClinicalTrials.Gov [Internet]. [cited 2024 Aug 18]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04627064"},{"key":"e_1_3_5_67_1","unstructured":"National Library of Medicine (U.S.). ClinicalTrials.Gov [Internet]. [cited 2024 Aug 18]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04626479"},{"key":"e_1_3_5_68_1","unstructured":"National Library of Medicine (U.S.). ClinicalTrials.Gov [Internet]. [cited 2024 Aug 18]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04626518"},{"key":"e_1_3_5_69_1","unstructured":"National Library of Medicine (U.S.). ClinicalTrials.Gov [Internet]. [cited 2024 Aug 18]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05239728"},{"key":"e_1_3_5_70_1","unstructured":"National Library of Medicine (U.S.). ClinicalTrials.Gov [Internet]. [cited 2024 Aug 18]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04736706"},{"key":"e_1_3_5_71_1","unstructured":"National Library of Medicine (U.S.). ClinicalTrials.Gov [Internet]. [cited 2024 Aug 18]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05899049"},{"key":"e_1_3_5_72_1","unstructured":"National Library of Medicine (U.S.). ClinicalTrials.Gov [Internet]. [cited 2024 Aug 18]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04586231"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyae181.004"},{"issue":"15","key":"e_1_3_5_74_1","first-page":"1336","article-title":"Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO\/ASH Clinical Practice Guideline Update","volume":"37","author":"Bohlius J","year":"2019","unstructured":"Bohlius J, Bohlke K, Castelli R, et al. Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO\/ASH Clinical Practice Guideline Update. J Clin Orthod. 2019;37(15):1336\u20131351.","journal-title":"J Clin Orthod"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605498"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012633.pub2"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2000.00211.x"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-14"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2024.102801"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.4_suppl.3"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201009-1393PP"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI137558"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0173-2022"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI133194"},{"key":"e_1_3_5_85_1","unstructured":"Center for Drug Evaluation Research. FDA approves belzutifan for cancers associated with von Hippel-Lindau disease[Internet]. U.S. Food and Drug Administration. FDA; 2024 [cited 2024 Aug 26]. Available from: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-belzutifan-cancers-associated-von-hippel-lindau-disease"},{"key":"e_1_3_5_86_1","unstructured":"Center for Drug Evaluation Research. FDA approves belzutifan for advanced renal cell carcinoma [Internet]. U.S. Food and Drug Administration. FDA; 2023 [cited 2024 Aug 26]. Available from: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-belzutifan-advanced-renal-cell-carcinoma"},{"key":"e_1_3_5_87_1","unstructured":"Orphan register [Internet]. GOV.UK; [cited 2024 Aug 19]. Available from: https:\/\/www.gov.uk\/government\/publications\/orphan-registered-medicinal-products\/orphan-register"},{"key":"e_1_3_5_88_1","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_280817"},{"key":"e_1_3_5_89_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.4809"},{"key":"e_1_3_5_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2022.102379"},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.10.090"},{"key":"e_1_3_5_92_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.4_suppl.361"},{"key":"e_1_3_5_93_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-006361"},{"key":"e_1_3_5_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2016.07.003"},{"key":"e_1_3_5_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2023.04.003"},{"key":"e_1_3_5_96_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-022-00676-0"},{"key":"e_1_3_5_97_1","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_430734"},{"key":"e_1_3_5_98_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-23-0680"},{"key":"e_1_3_5_99_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-1459"},{"key":"e_1_3_5_100_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.4_suppl.445"},{"key":"e_1_3_5_101_1","unstructured":"National Library of Medicine (U.S.). ClinicalTrials.Gov [Internet]. [cited 2024 Aug 18: Available from: https:\/\/clinicaltrials.gov\/study\/NCT05468697"},{"issue":"11","key":"e_1_3_5_102_1","first-page":"3014","article-title":"VHL-mediated hypoxia regulation of cyclin D1 in renal carcinoma cells","volume":"62","author":"Bindra RS","year":"2002","unstructured":"Bindra RS, Vasselli JR, Stearman R, et al. VHL-mediated hypoxia regulation of cyclin D1 in renal carcinoma cells. Cancer Res. 2002;62(11):3014\u20133019.","journal-title":"Cancer Res"},{"key":"e_1_3_5_103_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2204"},{"key":"e_1_3_5_104_1","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aay0482"},{"key":"e_1_3_5_105_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-024-00876-w"}],"container-title":["Expert Review of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17512433.2024.2436433","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T08:48:13Z","timestamp":1739782093000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17512433.2024.2436433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,13]]},"references-count":103,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.1080\/17512433.2024.2436433"],"URL":"https:\/\/doi.org\/10.1080\/17512433.2024.2436433","relation":{},"ISSN":["1751-2433","1751-2441"],"issn-type":[{"value":"1751-2433","type":"print"},{"value":"1751-2441","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,13]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-08-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}